This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Shiota, T. Articles by Muizelaar, J. P. Search for Related Content PubMed PubMed Citation Articles by Shiota, T. Articles by Muizelaar, J. P.

(Stroke. 1996;27:1889-1895.)
© 1996 American Heart Association, Inc.

Articles

Protein Kinase C Has Two Different Major Roles in Lattice Compaction Enhanced by Cerebrospinal Fluid From Patients With Subarachnoid Hemorrhage

Tomomi Shiota, MD; David H. Bernanke, PhD; Andrew D. Parent, MD Kouichi Hasui, MD

the Departments of Neurosurgery (T.S., D.H.B., A.D.P.) and Anatomy (D.H.B.), University of Mississippi Medical Center, Jackson, and Department of Neurological Surgery (K.H.), Kagawa Medical School, Takamatsu, Japan.

Correspondence to Tomomi Shiota, MD, c/o David H. Bernanke, PhD, Department of Neurosurgery, University of Mississippi Medical Center, 2500 N State St, Jackson, MS 39216-4505. E-mail dhb@umsmed.edu.

Background and Purpose Compaction of extracellular matrix (ECM) lattices by cultured fibroblasts was accelerated by cerebrospinal fluid (CSF) from patients with subarachnoid hemorrhage (SAH). The rate of acceleration was significantly related to the clinical grade of vasospasm. However, the mechanism remains unclear. Evidence exists for an important role in cerebral vasospasm for protein kinase C (PKC). The purpose of this study was to help clarify whether PKC has a role in contraction of the ECM.

Methods We studied the effects of a myristoylated PKC peptide inhibitor (Myr-Arg-Phe-Ala-Arg-Lys-Gly-Ala-Leu-Arg-Gln-Lys-Asn-Val) (PKC peptide inhibitor), (5-isoquinolinesulfonyl)homopiperazine (HA-1077) (inhibitor of protein kinase A, myosin light-chain kinase, and protein kinase G), 7-deacetyl-6-(N-acetylglycyl)-forskolin (forskolin) (adenyl cyclase activator), and diacylglycerol-lactone (DAG-lactone) (PKC activator) on fibroblast-populated collagen lattice compaction with or without CSF from SAH patients. Four sets of fibroblasts were used: three explanted from skin and one from cerebral artery.

Results Moderate and high concentrations of PKC peptide inhibitor inhibited lattice compaction with or without acceleration by CSF. Low concentration of PKC peptide inhibitor enhanced acceleration by CSF but had no effects without CSF. HA-1077 could not inhibit lattice compaction. Forskolin inhibited compaction. DAG-lactone accelerated compaction in early phases.

Conclusions In the mechanism of acceleration of contraction of ECM under the influence of CSF, PKC seems to have two different roles. Protein kinase A and myosin light-chain kinase apparently play more minor roles than PKC in the mechanism, but no evidence was found of a role for protein kinase G activation in matrix compaction.

Editorial Comment

J. Paul Muizelaar, MD, PhD, Guest Editor

Department of NeurosurgeryWayne State UniversityDetroit, Mich

This article has been cited by other articles:

				K. Fujimori, K. Kadoyama, and Y. Urade Protein Kinase C Activates Human Lipocalin-type Prostaglandin D Synthase Gene Expression through De-repression of Notch-HES Signaling and Enhancement of AP-2{beta} Function in Brain-derived TE671 Cells J. Biol. Chem., May 6, 2005; 280(18): 18452 - 18461. [Abstract] [Full Text] [PDF]